INNOSAFE Canadian Trademark Information

On Friday, June 14, 2013, a canadian trademark registration was filed for INNOSAFE by Elanco US Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1631275. The current status of this trademark filing is Registration published. The INNOSAFE trademark is filed in the description of Veterinary preparations, namely, vaccines, antimicrobials, namely, oral and injectable veterinary preparations for the treatment and control of infectious disease in food producing animals and livestock, antivirals, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, non-infectious and metabolic diseases in animals namely Ketosis, Brucellosis, hypomagnesaemia, milk fever, fat cow syndrome, E. Coli, salmonella, mad cow disease, Cryptosporidium, Campylobacter, bacillus anthracis, oral preparations for growth promotant; medicated animal feed and water additives in the nature of dietary supplements for the production enhancement of livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; Veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain relief, inflammation, gastrointestinal disorders, central nervous system disorders namely cerebellar hypoplasia, cerebellar abiotrophy, laryngeal paralysis, meningoencephalitis, syringomyelia, neurological and neurodegenerative disorders namely seizure and epilepsy, cardiovascular conditions, dermatologic conditions, namely canine atopic dermatitis, skin rash, flea allergy, and food allergy, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections associated with acaricides, heartworm, GI nematodes, mange and fleas, allergy atopic conditions, liver diseases and disorders, nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely vaccines for companion animals. , Veterinary preparations, namely, vaccines, antimicrobials, namely, oral and injectable veterinary preparations for the treatment and control of infectious disease in food producing animals and livestock, antivirals, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, non-infectious and metabolic diseases in animals namely Ketosis, Brucellosis, hypomagnesaemia, milk fever, fat cow syndrome, E. Coli, salmonella, mad cow disease, Cryptosporidium, Campylobacter, bacillus anthracis, oral preparations for growth promotant; medicated animal feed and water additives in the nature of dietary supplements for the production enhancement of livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; Veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain relief, inflammation, gastrointestinal disorders, central nervous system disorders namely cerebellar hypoplasia, cerebellar abiotrophy, laryngeal paralysis, meningoencephalitis, syringomyelia, neurological and neurodegenerative disorders namely seizure and epilepsy, cardiovascular conditions, dermatologic conditions, namely canine atopic dermatitis, skin rash, flea allergy, and food allergy, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections associated with acaricides, heartworm, GI nematodes, mange and fleas, allergy atopic conditions, liver diseases and disorders, nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely vaccines for companion animals. .